title: In vitro cytokine profiles and their relevance to rejection following renal transplantation.
abstract: Graft rejection remains an important cause of renal allograft failure, despite improvements in immunosuppression and HLA typing. Although HLA matching is beneficial, ensuring an exact match it is often impractical. Thus, a reliable in vitro method for quantitating and qualitating alloreactivity is an important goal. In this study, we measured in vitro the cytokine secretion profiles of mononuclear cells from patients prior to renal transplantation by stimulating with anti-CD3 monoclonal antibody and suppressing with cyclosporine. Mononuclear cells from patients who subsequently developed acute cellular rejection secreted higher mean levels of interleukin (IL)-2 and gamma-interferon (IFN-gamma) than those from patients who had no rejection episodes. IFN-gamma secretion was significantly associated with rejection (P = 0.002), whereas IL-2 secretion did not quite reach statistical significance. There was no significant correlation between IL-4 levels and rejection. Although cyclosporine suppressed the secretion of both IL-2 and IFN-gamma, there was no difference in sensitivity to suppression between rejectors and nonrejectors. These results further emphasize the importance of the TH1 lymphocyte subset in renal allograft rejection. The IFN-gamma secretory capacity of alloreactive T cells may influence the outcome of a renal allograft by (1) activating graft infiltrating macrophages and/or (2) up-regulating HLA molecules on the graft.
authors.affiliation: Department of Immunology, St. Helier Hospital, Carshalton, Surrey, UK.
authors.forename: E R
authors.initials: ER
authors.lastname: Kaminski
authors.forename: A
authors.initials: A
authors.lastname: Kaminski
authors.forename: M R
authors.initials: MR
authors.lastname: Bending
authors.forename: R
authors.initials: R
authors.lastname: Chang
authors.forename: A
authors.initials: A
authors.lastname: Heads
authors.forename: R M
authors.initials: RM
authors.lastname: Szydlo
authors.forename: R S
authors.initials: RS
authors.lastname: Pereira
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002102:Cadaver; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism*; D006084:Graft Rejection / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D011446:Prospective Studies; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D016207:Cytokines; D016572:Cyclosporine